chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 71.0
Sex: F
Vaccine: UNK
Symptoms: Arthralgia, Decreased appetite, Influenza like illness, Pain, Sinus pain
Clinical narrative: Excruciating pain all over my body. Flu-like symptoms with sinus pain. Could not even wear glasses because the weight of the frames hurt my face that bad. The second day the pain migrated into my teeth, though I had been to the dentist about a month earlier and had no dental issues. Even xrays were taken.  Joint pain.  Loss of appetite.  The pain eventually disappeared by the morning of February 22, 2021.
Age: 71.0
Sex: F
Vaccine: UNK
Symptoms: Toothache
Clinical narrative: Excruciating pain all over my body. Flu-like symptoms with sinus pain. Could not even wear glasses because the weight of the frames hurt my face that bad. The second day the pain migrated into my teeth, though I had been to the dentist about a month earlier and had no dental issues. Even xrays were taken.  Joint pain.  Loss of appetite.  The pain eventually disappeared by the morning of February 22, 2021.
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Axillary pain, Discomfort, Headache, Lymphadenopathy
Clinical narrative: 1. Minor headache 2. Moderate pain in left underarm. Minor swelling of lymph node in the same area. I feel discomfort when trying to place my arm against my body. I have to keep arm extended to avoid discomfort.
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Headache, Pain
Clinical narrative: Systemic: Chest Tightness / Heaviness / Pain-Mild, Systemic: Headache-Mild
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site bruising, Injection site erythema, Myalgia
Clinical narrative: Site: Bruising at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Additional Details: PATIENT PRESENTED FOR SECOND SHOT, STATING SHE STILL HAS MUSCLE PAIN FROM 1ST SHOT 21 DAYS AGO. IN ADDITION THERE WAS STILL BRUISING, AND SOME UNIDENTIFIED RED SPOTS. I INSTRUCTED HER TO CONSULT HER DOCTORE, WHICH SHE HAD NOT YET, AS THIS COULD BE A SIGN OF SOMETHING THAT REQUIRES MEDICAL TREATMENT
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Insomnia, Limb discomfort, Nausea, Pain
Clinical narrative: Sore arm, sore body, nausea, can't sleep.  No side effect from first shot.
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity
Clinical narrative: AFTER RECEIVING THE VACCINE, SHE SAID SHE WAS HAVING AN ALLERGIC REACTION. ON SITE EMS RESPONDED. BP 114/72 HR 72. SHE REFUSED FURTHER EVALUATION OR CARE.
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Injection site pain
Clinical narrative: pain in left arm  started days after shot
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Dizziness, Headache, Insomnia, Nausea
Clinical narrative: Elevated high pressure, nauseas, dizziness and strong headaches. Couldn't sleep well.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Flushing, Hyperhidrosis, Injection site erythema, Injection site pain
Clinical narrative: Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Fever-Medium, Systemic: Flushed / Sweating-Medium
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site swelling, Lethargy, Pyrexia
Clinical narrative: Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Fever-Medium, Systemic: Flushed / Sweating-Medium
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Swelling
Clinical narrative: Red itchy raised bump Hot to touch
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Error: Wrong Dose of Vaccine - Too High
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Lethargy, Nausea, Syncope
Clinical narrative: Systemic: Dizziness / Lightheadness-Mild, Systemic: Exhaustion / Lethargy-Mild, Systemic: Fainting / Unresponsive-Mild, Systemic: pt was not responding well, urinated on self and felt nauseas. Pt is on hospice and felt dizzy even before the vaccine.-Mild, Systemic: Nausea-Mild, Additional Details: Pt was dizzy and fell 02/21/21 at the site; paramedics called; refused to be hospitalized. Pt vaccinated 02/22/21, was dizzy and urinated on self,  paramedics called, refused to be hospitalized. Staff told vaccinators then that pt was hospice and own guardian, so nothing could be done.
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Unresponsive to stimuli, Urinary incontinence
Clinical narrative: Systemic: Dizziness / Lightheadness-Mild, Systemic: Exhaustion / Lethargy-Mild, Systemic: Fainting / Unresponsive-Mild, Systemic: pt was not responding well, urinated on self and felt nauseas. Pt is on hospice and felt dizzy even before the vaccine.-Mild, Systemic: Nausea-Mild, Additional Details: Pt was dizzy and fell 02/21/21 at the site; paramedics called; refused to be hospitalized. Pt vaccinated 02/22/21, was dizzy and urinated on self,  paramedics called, refused to be hospitalized. Staff told vaccinators then that pt was hospice and own guardian, so nothing could be done.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Seizure
Clinical narrative: The next day of vaccination, early in the morning wake up having convulsions.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: Sore shoulder
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Facial discomfort, Paraesthesia oral, Rash
Clinical narrative: Started to feel face heat and lips tingle slight rash on cheeks and bridge of nose
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia oral, Rash, Rash erythematous
Clinical narrative: Started to feel face heat and lips tingle slight rash on cheeks and bridge of nose
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness
Clinical narrative: Pt. from tent 3 at observation lane was complaining of light headedness + generalized weakness.  Paramedics assessed.  Once symptoms subsided paramedics released pt. to leave.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus
Clinical narrative: Red itchy rash about 1.5? below where the shot was  It?s about 2.5? long and 1? wide.
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site reaction, Injection site warmth, Local reaction
Clinical narrative: left arm deltoid region is erythemous, tender to touch, and warm. local reaction to at covid injection site.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia oral
Clinical narrative: Shot was given at approximately 9:05 a.m.  Waited the 15 minutes and left the mega-site at approximately 9:30 a.m.  On the drive home, approximately 5-10 minutes into the drive my tongue and roof of my mouth started to tingle.  Got home in about 15 minutes.  Once home, I drank some water.  Slowly the tingling of the tongue and roof of mouth disappeared.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Dizziness, Headache, Hot flush, Hypoaesthesia
Clinical narrative: Immediately  felt faint and dizzy,vasovagal  reaction exacerbated, I get menopausal  hot flashes this was intensified 10 x and immediate pain top head,B/p went up,felt numb face extremities, cancelled 2nd injection and B/p still up currently still feel dizzy and pain top head
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Presyncope
Clinical narrative: Immediately  felt faint and dizzy,vasovagal  reaction exacerbated, I get menopausal  hot flashes this was intensified 10 x and immediate pain top head,B/p went up,felt numb face extremities, cancelled 2nd injection and B/p still up currently still feel dizzy and pain top head
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: Pt left tent 13 to observation lane.  Pt. was complaining of tingling hands.  Paramedics monitored until symptoms subsided.  Paramedics released pt. to leave.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Hot flush, Hyperhidrosis
Clinical narrative: HE WAS HOT, FLUSHING SWEATING 5 MINUTES AFTER RECEIVING THE VACCINE. ON SITE EMS RESPONDED. BP 163/76  HR 90. AFTER 10 MINUTES HE FELT FINE AND LEFT FOR HOME
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Joint stiffness
Clinical narrative: Stiff  and sore left arm at injection site, redness and swelling. Ice packs and betamethasone cream. Advil. Resolved within 2 days
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pain, Pyrexia
Clinical narrative: 8 hours after, fever, chills, body aches. 5 days later, severe headache that has lasted over a week (9 days)
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles at the right L1-2 dermatome
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Hyperhidrosis
Clinical narrative: 42 YEAR OLD MALE WAS DIAPHRETIC AFTER RECEIVING VACCINE.  HE WAS ALSO TALKITIVE AND ALERT.  ON SITE EMS RESPONDED.  BP 104/80  HR 71 PULSE OX 96% GLUCOSE 82 MG/DL His wife got in the drivers seat and left for home
Sex: U
Vaccine: VARZOS
Symptoms: Arthralgia, Myalgia
Clinical narrative: some pain in the joints and in mussels; some pain in the joints and in mussels; This case was reported by a consumer and described the occurrence of joint pain in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On 30th December 2020, the patient received Shingrix. On 30th December 2020, less than a day after receiving Shingrix, the patient experienced joint pain and muscle pain. On an unknown date, the outcome of the joint pain and muscle pain were unknown.   It was unknown if the reporter considered the joint pain and muscle pain to be related to Shingrix.  Additional details were reported as follows: This case was reported by patient him/herself. The age at vaccination was not reported. The age group was not reported but was selected as an adult as per vaccine indication. The patient received Shingrix and on the same day, experienced some pain in the joints and in muscle.
Age: 60.0
Sex: M
Vaccine: VARZOS
Symptoms: Balance disorder, Blood test normal, Dizziness, Feeling abnormal, Gait disturbance
Clinical narrative: disoriented gait; balance problems going up stairs; dizziness when turning head side to side; brain fog; This case was reported by a physician via call center representative and described the occurrence of unsteady gait in a 60-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 18th August 2020, the patient received the 1st dose of Shingrix (intramuscular). On 25th August 2020, 7 days after receiving Shingrix, the patient experienced unsteady gait, balance difficulty, dizziness and foggy feeling in head. On an unknown date, the outcome of the unsteady gait, balance difficulty, dizziness and foggy feeling in head were recovering/resolving.   It was unknown if the reporter considered the unsteady gait, balance difficulty, dizziness and foggy feeling in head to be related to Shingrix.  Additional details were reported as follows: The patient began to experience dizziness when turning head side to side, disoriented gait, balance problems going up stairs, and brain fog. The patient was examined by a neurologist and had an MRI (magnetic resonance imaging) and bloodwork, but there were no abnormal findings.  The patient had a follow visit with primary care physician on 1st February 2021, and the physician reported there were some slight improvements in the patient's adverse events. The reporter consented to follow-up.
Age: 60.0
Sex: M
Vaccine: VARZOS
Symptoms: Magnetic resonance imaging
Clinical narrative: disoriented gait; balance problems going up stairs; dizziness when turning head side to side; brain fog; This case was reported by a physician via call center representative and described the occurrence of unsteady gait in a 60-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 18th August 2020, the patient received the 1st dose of Shingrix (intramuscular). On 25th August 2020, 7 days after receiving Shingrix, the patient experienced unsteady gait, balance difficulty, dizziness and foggy feeling in head. On an unknown date, the outcome of the unsteady gait, balance difficulty, dizziness and foggy feeling in head were recovering/resolving.   It was unknown if the reporter considered the unsteady gait, balance difficulty, dizziness and foggy feeling in head to be related to Shingrix.  Additional details were reported as follows: The patient began to experience dizziness when turning head side to side, disoriented gait, balance problems going up stairs, and brain fog. The patient was examined by a neurologist and had an MRI (magnetic resonance imaging) and bloodwork, but there were no abnormal findings.  The patient had a follow visit with primary care physician on 1st February 2021, and the physician reported there were some slight improvements in the patient's adverse events. The reporter consented to follow-up.
Sex: U
Vaccine: DTAPIPVHIB
Symptoms: Peripheral swelling
Clinical narrative: severe swelling in the leg from knee to hip; Initial information received on 11-Jan-2021 regarding an unsolicited valid non-serious case received from a consumer.  This case involves patient (unknown demographic) who experienced severe swelling in the leg from knee to hip (swelling), while he/she received vaccine DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL].  It is unknown if the patient had any medical history, concomitant disease or risk factor.  Medical treatment, vaccination, concomitant medication and family history were not provided.  On an unknown date, the patient received a dose of suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE (lot UJ162AB and expiry date: not reported) (Suspension for injection) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious severe swelling in the leg from knee to hip (swelling) (unknown latency) following the administration of DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE.  It is unknown if the patient experienced any additional symptoms/events.  It is unknown if there were lab data/results available.  It was not reported if the patient received a corrective treatment.  At the time of reporting, the outcome of event was reported as unknown.
Sex: U
Vaccine: FLUX
Symptoms: Bursitis
Clinical narrative: Injection in joint leading to bursitis; Initial information received on 03-Feb-2021 regarding an unsolicited valid non-serious case received from a pharmacist .  This case involves patient (unknown demographics) who experienced injection in joint leading to bursitis (bursitis), while he/she received vaccine INFLUENZA VACCINE.  It is unknown if the patient had any medical history, concomitant disease or risk factor.  Medical treatment, vaccination, concomitant medication and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date: not reported) via an unknown route in unknown administration site.  On an unknown date, the patient developed a non-serious injection in joint leading to bursitis (bursitis) (unknown latency) following the administration of INFLUENZA VACCINE.  It is unknown if there were lab data/results available.  It was not reported if the patient received a corrective treatment.  It is unknown if the patient experienced any additional symptoms/events.  At the time of reporting, the outcome of event was reported as unknown.  There will be no information available on the batch number for this case.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Pharyngeal swelling
Clinical narrative: My epoglottis began swelling about 8-10 hours after the shot.  It was minor, and I did not see a doctor., nor did I take any meds or treatment The swelling was gone by the next morning.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia
Clinical narrative: Loss of taste, specifically coffee. Called doctor, advised by nurse to report to VAERS, awaiting doctor recommendation
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Paraesthesia oral, Pruritus, Swelling face
Clinical narrative: Patient informed the clinic that he began feeling "itchy like bugs crawling all over" on 2/16/21.  He proceeded to take Benadryl which was effective.  On 2/20/21 he woke up with swelling on the left side of his face.   On 2/21/21 he woke up with swelling on the right side of the mouth and reported "tingling like I just went to the dentist".  Symptoms were resolved by 2/22/21.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Dysphonia, Dyspnoea, Erythema, Lip swelling, Pharyngeal swelling
Clinical narrative: SOB, Hives, Reddness, Swelling in throat and lips. hoarseness and wheezing
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Wheezing
Clinical narrative: SOB, Hives, Reddness, Swelling in throat and lips. hoarseness and wheezing
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Injection site pruritus, Injection site rash
Clinical narrative: COVID arm - delayed reaction rash - itching - mild pain.
Age: 40.0
Sex: M
Vaccine: FLUN4
Symptoms: Agitation, Anti-ganglioside antibody positive, Areflexia, Back pain, Burning sensation
Clinical narrative: Patient describes receipt of LAIV (lot #50110 7P Nov 3, 2011; dose #15) and onset of  double vision changes in December. Progressive symptoms were loss of speech enunciation, difficulty clearing throat, and burning sensation and numbness of upper back and  arms. He was diagnosed GBS Miller-Fisher variant in later January and treated with inpatient IVIG.  He would like to receive flu vaccine if can be done safely.  He does recall significant GI illness with severe diarrhea prior to GBS diagnosis. He also reports episodes of frequent pneumonia, and believes has had at least 5, confirmed by CXR (we found documentation of two, f/u immune function eval results normal) Per event note:  Per notes 02 FEB 12: Admitted to Neurology with acute onset of pseudobulbar palsy (dysphagia, dysphonia), diplopia, unsteady gait, and rapidly developing dysarthria, associated with paresthesias and pain in the extremities, and then leading to areflexia, all with a normal sensorium.  Symptoms started on 19 JAN.  He had negative brain / C-spine MRI, negative EEG, negative myasthenia testing, and NCV/EMG testing suspicious for Guillain-Barre syndrome.  Plus, he had positive antibodies to ganglioside GQ1b, pathognomonic of Miller-Fisher syndrome.  He was treated with 5 days of IVIG, and rapidly improved, with normalization of all bulbar symptoms.  He had persistent back pain and limb paresthesias, as well as feeling "juiced up" and very agitated.  Admission dates: 22 JAN - 02 FEB 2012.
Age: 40.0
Sex: M
Vaccine: FLUN4
Symptoms: Chest X-ray abnormal, Diarrhoea, Diplopia, Dysarthria, Dysphagia
Clinical narrative: Patient describes receipt of LAIV (lot #50110 7P Nov 3, 2011; dose #15) and onset of  double vision changes in December. Progressive symptoms were loss of speech enunciation, difficulty clearing throat, and burning sensation and numbness of upper back and  arms. He was diagnosed GBS Miller-Fisher variant in later January and treated with inpatient IVIG.  He would like to receive flu vaccine if can be done safely.  He does recall significant GI illness with severe diarrhea prior to GBS diagnosis. He also reports episodes of frequent pneumonia, and believes has had at least 5, confirmed by CXR (we found documentation of two, f/u immune function eval results normal) Per event note:  Per notes 02 FEB 12: Admitted to Neurology with acute onset of pseudobulbar palsy (dysphagia, dysphonia), diplopia, unsteady gait, and rapidly developing dysarthria, associated with paresthesias and pain in the extremities, and then leading to areflexia, all with a normal sensorium.  Symptoms started on 19 JAN.  He had negative brain / C-spine MRI, negative EEG, negative myasthenia testing, and NCV/EMG testing suspicious for Guillain-Barre syndrome.  Plus, he had positive antibodies to ganglioside GQ1b, pathognomonic of Miller-Fisher syndrome.  He was treated with 5 days of IVIG, and rapidly improved, with normalization of all bulbar symptoms.  He had persistent back pain and limb paresthesias, as well as feeling "juiced up" and very agitated.  Admission dates: 22 JAN - 02 FEB 2012.
Age: 40.0
Sex: M
Vaccine: FLUN4
Symptoms: Dysphonia, Electroencephalogram normal, Electromyogram abnormal, Feeling abnormal, Gait disturbance
Clinical narrative: Patient describes receipt of LAIV (lot #50110 7P Nov 3, 2011; dose #15) and onset of  double vision changes in December. Progressive symptoms were loss of speech enunciation, difficulty clearing throat, and burning sensation and numbness of upper back and  arms. He was diagnosed GBS Miller-Fisher variant in later January and treated with inpatient IVIG.  He would like to receive flu vaccine if can be done safely.  He does recall significant GI illness with severe diarrhea prior to GBS diagnosis. He also reports episodes of frequent pneumonia, and believes has had at least 5, confirmed by CXR (we found documentation of two, f/u immune function eval results normal) Per event note:  Per notes 02 FEB 12: Admitted to Neurology with acute onset of pseudobulbar palsy (dysphagia, dysphonia), diplopia, unsteady gait, and rapidly developing dysarthria, associated with paresthesias and pain in the extremities, and then leading to areflexia, all with a normal sensorium.  Symptoms started on 19 JAN.  He had negative brain / C-spine MRI, negative EEG, negative myasthenia testing, and NCV/EMG testing suspicious for Guillain-Barre syndrome.  Plus, he had positive antibodies to ganglioside GQ1b, pathognomonic of Miller-Fisher syndrome.  He was treated with 5 days of IVIG, and rapidly improved, with normalization of all bulbar symptoms.  He had persistent back pain and limb paresthesias, as well as feeling "juiced up" and very agitated.  Admission dates: 22 JAN - 02 FEB 2012.
Age: 40.0
Sex: M
Vaccine: FLUN4
Symptoms: Gastrointestinal disorder, Guillain-Barre syndrome, Hypoaesthesia, Immunoglobulin therapy, Magnetic resonance imaging head normal
Clinical narrative: Patient describes receipt of LAIV (lot #50110 7P Nov 3, 2011; dose #15) and onset of  double vision changes in December. Progressive symptoms were loss of speech enunciation, difficulty clearing throat, and burning sensation and numbness of upper back and  arms. He was diagnosed GBS Miller-Fisher variant in later January and treated with inpatient IVIG.  He would like to receive flu vaccine if can be done safely.  He does recall significant GI illness with severe diarrhea prior to GBS diagnosis. He also reports episodes of frequent pneumonia, and believes has had at least 5, confirmed by CXR (we found documentation of two, f/u immune function eval results normal) Per event note:  Per notes 02 FEB 12: Admitted to Neurology with acute onset of pseudobulbar palsy (dysphagia, dysphonia), diplopia, unsteady gait, and rapidly developing dysarthria, associated with paresthesias and pain in the extremities, and then leading to areflexia, all with a normal sensorium.  Symptoms started on 19 JAN.  He had negative brain / C-spine MRI, negative EEG, negative myasthenia testing, and NCV/EMG testing suspicious for Guillain-Barre syndrome.  Plus, he had positive antibodies to ganglioside GQ1b, pathognomonic of Miller-Fisher syndrome.  He was treated with 5 days of IVIG, and rapidly improved, with normalization of all bulbar symptoms.  He had persistent back pain and limb paresthesias, as well as feeling "juiced up" and very agitated.  Admission dates: 22 JAN - 02 FEB 2012.
Age: 40.0
Sex: M
Vaccine: FLUN4
Symptoms: Magnetic resonance imaging spinal normal, Miller Fisher syndrome, Nerve conduction studies abnormal, Pain in extremity, Paraesthesia
Clinical narrative: Patient describes receipt of LAIV (lot #50110 7P Nov 3, 2011; dose #15) and onset of  double vision changes in December. Progressive symptoms were loss of speech enunciation, difficulty clearing throat, and burning sensation and numbness of upper back and  arms. He was diagnosed GBS Miller-Fisher variant in later January and treated with inpatient IVIG.  He would like to receive flu vaccine if can be done safely.  He does recall significant GI illness with severe diarrhea prior to GBS diagnosis. He also reports episodes of frequent pneumonia, and believes has had at least 5, confirmed by CXR (we found documentation of two, f/u immune function eval results normal) Per event note:  Per notes 02 FEB 12: Admitted to Neurology with acute onset of pseudobulbar palsy (dysphagia, dysphonia), diplopia, unsteady gait, and rapidly developing dysarthria, associated with paresthesias and pain in the extremities, and then leading to areflexia, all with a normal sensorium.  Symptoms started on 19 JAN.  He had negative brain / C-spine MRI, negative EEG, negative myasthenia testing, and NCV/EMG testing suspicious for Guillain-Barre syndrome.  Plus, he had positive antibodies to ganglioside GQ1b, pathognomonic of Miller-Fisher syndrome.  He was treated with 5 days of IVIG, and rapidly improved, with normalization of all bulbar symptoms.  He had persistent back pain and limb paresthesias, as well as feeling "juiced up" and very agitated.  Admission dates: 22 JAN - 02 FEB 2012.
Age: 40.0
Sex: M
Vaccine: FLUN4
Symptoms: Pneumonia, Pseudobulbar palsy, Speech disorder, Throat clearing
Clinical narrative: Patient describes receipt of LAIV (lot #50110 7P Nov 3, 2011; dose #15) and onset of  double vision changes in December. Progressive symptoms were loss of speech enunciation, difficulty clearing throat, and burning sensation and numbness of upper back and  arms. He was diagnosed GBS Miller-Fisher variant in later January and treated with inpatient IVIG.  He would like to receive flu vaccine if can be done safely.  He does recall significant GI illness with severe diarrhea prior to GBS diagnosis. He also reports episodes of frequent pneumonia, and believes has had at least 5, confirmed by CXR (we found documentation of two, f/u immune function eval results normal) Per event note:  Per notes 02 FEB 12: Admitted to Neurology with acute onset of pseudobulbar palsy (dysphagia, dysphonia), diplopia, unsteady gait, and rapidly developing dysarthria, associated with paresthesias and pain in the extremities, and then leading to areflexia, all with a normal sensorium.  Symptoms started on 19 JAN.  He had negative brain / C-spine MRI, negative EEG, negative myasthenia testing, and NCV/EMG testing suspicious for Guillain-Barre syndrome.  Plus, he had positive antibodies to ganglioside GQ1b, pathognomonic of Miller-Fisher syndrome.  He was treated with 5 days of IVIG, and rapidly improved, with normalization of all bulbar symptoms.  He had persistent back pain and limb paresthesias, as well as feeling "juiced up" and very agitated.  Admission dates: 22 JAN - 02 FEB 2012.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Gait disturbance, Migraine, Pain
Clinical narrative: woke during the night with chills, body aches, and migraines, hurts to walk
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Axillary pain, Body temperature increased, Injection site pain, Myalgia, Pain
Clinical narrative: temp 100.5 chills, muscle  pain, injection site pain radiating to left armpit which last for 2 weeks
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Device connection issue, Syringe issue
Clinical narrative: Syringe malfunctioned, causing some of the vaccine to end up on the skin, rather than in the patient
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site induration, Injection site rash
Clinical narrative: "Covid arm" -- redness, rash and hardness 8-9 days after injection,
Age: 82.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain, Abdominal pain lower, Alanine aminotransferase decreased, Angiogram, Anion gap
Clinical narrative: Pt with no previous history of abdominal aortic aneurysm presented to ER on 02.20.2021 with abdominal pain, weakness and BP of 50/30 via EMS. Abdominal pain started on 02.19.2021 approx 10:00 PM. Pain was described as severe in the left flank, radiating into the lower abdomen and worsened through the night. EMS was called around 11 AM.  Pt CT Abd/Pelvis angiography shown Ruptured abdominal aortic aneurysm measuring up to 7.9 cm in diameter and 9.8 cm in length with active extravasation of IV contrast. Large volume of predominantly retroperitoneal hemorrhage. Pt was flown hospital for surgical intervention after being given 2 units of O neg blood with 2 L normal saline.
Age: 82.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Aortic aneurysm rupture, Aspartate aminotransferase normal, Asthenia, Atelectasis, Blood albumin decreased
Clinical narrative: Pt with no previous history of abdominal aortic aneurysm presented to ER on 02.20.2021 with abdominal pain, weakness and BP of 50/30 via EMS. Abdominal pain started on 02.19.2021 approx 10:00 PM. Pain was described as severe in the left flank, radiating into the lower abdomen and worsened through the night. EMS was called around 11 AM.  Pt CT Abd/Pelvis angiography shown Ruptured abdominal aortic aneurysm measuring up to 7.9 cm in diameter and 9.8 cm in length with active extravasation of IV contrast. Large volume of predominantly retroperitoneal hemorrhage. Pt was flown hospital for surgical intervention after being given 2 units of O neg blood with 2 L normal saline.
Age: 82.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood alkaline phosphatase decreased, Blood bilirubin normal, Blood calcium decreased, Blood chloride increased, Blood creatinine normal
Clinical narrative: Pt with no previous history of abdominal aortic aneurysm presented to ER on 02.20.2021 with abdominal pain, weakness and BP of 50/30 via EMS. Abdominal pain started on 02.19.2021 approx 10:00 PM. Pain was described as severe in the left flank, radiating into the lower abdomen and worsened through the night. EMS was called around 11 AM.  Pt CT Abd/Pelvis angiography shown Ruptured abdominal aortic aneurysm measuring up to 7.9 cm in diameter and 9.8 cm in length with active extravasation of IV contrast. Large volume of predominantly retroperitoneal hemorrhage. Pt was flown hospital for surgical intervention after being given 2 units of O neg blood with 2 L normal saline.
Age: 82.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood glucose increased, Blood lactic acid increased, Blood potassium normal, Blood sodium normal, Blood urea normal
Clinical narrative: Pt with no previous history of abdominal aortic aneurysm presented to ER on 02.20.2021 with abdominal pain, weakness and BP of 50/30 via EMS. Abdominal pain started on 02.19.2021 approx 10:00 PM. Pain was described as severe in the left flank, radiating into the lower abdomen and worsened through the night. EMS was called around 11 AM.  Pt CT Abd/Pelvis angiography shown Ruptured abdominal aortic aneurysm measuring up to 7.9 cm in diameter and 9.8 cm in length with active extravasation of IV contrast. Large volume of predominantly retroperitoneal hemorrhage. Pt was flown hospital for surgical intervention after being given 2 units of O neg blood with 2 L normal saline.
Age: 82.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Carbon dioxide decreased, Computerised tomogram abdomen, Flank pain, Full blood count, Globulins decreased
Clinical narrative: Pt with no previous history of abdominal aortic aneurysm presented to ER on 02.20.2021 with abdominal pain, weakness and BP of 50/30 via EMS. Abdominal pain started on 02.19.2021 approx 10:00 PM. Pain was described as severe in the left flank, radiating into the lower abdomen and worsened through the night. EMS was called around 11 AM.  Pt CT Abd/Pelvis angiography shown Ruptured abdominal aortic aneurysm measuring up to 7.9 cm in diameter and 9.8 cm in length with active extravasation of IV contrast. Large volume of predominantly retroperitoneal hemorrhage. Pt was flown hospital for surgical intervention after being given 2 units of O neg blood with 2 L normal saline.
Age: 82.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Glomerular filtration rate decreased, Haematocrit decreased, Haemoglobin decreased, Infusion site extravasation, International normalised ratio increased
Clinical narrative: Pt with no previous history of abdominal aortic aneurysm presented to ER on 02.20.2021 with abdominal pain, weakness and BP of 50/30 via EMS. Abdominal pain started on 02.19.2021 approx 10:00 PM. Pain was described as severe in the left flank, radiating into the lower abdomen and worsened through the night. EMS was called around 11 AM.  Pt CT Abd/Pelvis angiography shown Ruptured abdominal aortic aneurysm measuring up to 7.9 cm in diameter and 9.8 cm in length with active extravasation of IV contrast. Large volume of predominantly retroperitoneal hemorrhage. Pt was flown hospital for surgical intervention after being given 2 units of O neg blood with 2 L normal saline.
Age: 82.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Mean cell haemoglobin concentration normal, Mean cell volume normal, Metabolic function test, Pain, Platelet count decreased
Clinical narrative: Pt with no previous history of abdominal aortic aneurysm presented to ER on 02.20.2021 with abdominal pain, weakness and BP of 50/30 via EMS. Abdominal pain started on 02.19.2021 approx 10:00 PM. Pain was described as severe in the left flank, radiating into the lower abdomen and worsened through the night. EMS was called around 11 AM.  Pt CT Abd/Pelvis angiography shown Ruptured abdominal aortic aneurysm measuring up to 7.9 cm in diameter and 9.8 cm in length with active extravasation of IV contrast. Large volume of predominantly retroperitoneal hemorrhage. Pt was flown hospital for surgical intervention after being given 2 units of O neg blood with 2 L normal saline.
Age: 82.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Protein albumin ratio normal, Protein total decreased, Prothrombin time prolonged, Red blood cell count decreased, Red cell distribution width normal
Clinical narrative: Pt with no previous history of abdominal aortic aneurysm presented to ER on 02.20.2021 with abdominal pain, weakness and BP of 50/30 via EMS. Abdominal pain started on 02.19.2021 approx 10:00 PM. Pain was described as severe in the left flank, radiating into the lower abdomen and worsened through the night. EMS was called around 11 AM.  Pt CT Abd/Pelvis angiography shown Ruptured abdominal aortic aneurysm measuring up to 7.9 cm in diameter and 9.8 cm in length with active extravasation of IV contrast. Large volume of predominantly retroperitoneal hemorrhage. Pt was flown hospital for surgical intervention after being given 2 units of O neg blood with 2 L normal saline.
Age: 82.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Retroperitoneal haemorrhage, SARS-CoV-2 antibody test negative, Transfusion, Troponin normal, Urine analysis normal
Clinical narrative: Pt with no previous history of abdominal aortic aneurysm presented to ER on 02.20.2021 with abdominal pain, weakness and BP of 50/30 via EMS. Abdominal pain started on 02.19.2021 approx 10:00 PM. Pain was described as severe in the left flank, radiating into the lower abdomen and worsened through the night. EMS was called around 11 AM.  Pt CT Abd/Pelvis angiography shown Ruptured abdominal aortic aneurysm measuring up to 7.9 cm in diameter and 9.8 cm in length with active extravasation of IV contrast. Large volume of predominantly retroperitoneal hemorrhage. Pt was flown hospital for surgical intervention after being given 2 units of O neg blood with 2 L normal saline.
Age: 82.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: White blood cell count increased
Clinical narrative: Pt with no previous history of abdominal aortic aneurysm presented to ER on 02.20.2021 with abdominal pain, weakness and BP of 50/30 via EMS. Abdominal pain started on 02.19.2021 approx 10:00 PM. Pain was described as severe in the left flank, radiating into the lower abdomen and worsened through the night. EMS was called around 11 AM.  Pt CT Abd/Pelvis angiography shown Ruptured abdominal aortic aneurysm measuring up to 7.9 cm in diameter and 9.8 cm in length with active extravasation of IV contrast. Large volume of predominantly retroperitoneal hemorrhage. Pt was flown hospital for surgical intervention after being given 2 units of O neg blood with 2 L normal saline.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site rash
Clinical narrative: I got a rash in the area where the 1st vaccine was  after my 2nd shot. Went to my primary and was given an antibiotic. took pill for couple of days and it cleared up  after a day and a half.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site paraesthesia
Clinical narrative: Tingling in left shoulder blade and left arm
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Decreased appetite, Endotracheal intubation, Fatigue, Headache, Intensive care
Clinical narrative: 2/9 received 2nd vaccine in series. 2/10 mild headache and fatigue. 2/11 worsening headache, extreme fatigue, and general malaise. In bed except for bathroom use and minimal food consumption starting 2/11 until hospitalization on 2/17/2021.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Malaise, Pneumonia
Clinical narrative: 2/9 received 2nd vaccine in series. 2/10 mild headache and fatigue. 2/11 worsening headache, extreme fatigue, and general malaise. In bed except for bathroom use and minimal food consumption starting 2/11 until hospitalization on 2/17/2021.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Aphonia, Arthralgia, Fatigue, Headache, Injection site erythema
Clinical narrative: About 30 minutes after receiving the vaccine I began to lose my voice. I also had a headache, joint pain and felt fatigue later that evening and it lasted until the 23rd.  On the 23rd I developed a fever of 101. Today I still do not have my voice and the fever has went away. The injection site has a red and swollen patch. I still feel tired and fatigued today.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site swelling, Pyrexia
Clinical narrative: About 30 minutes after receiving the vaccine I began to lose my voice. I also had a headache, joint pain and felt fatigue later that evening and it lasted until the 23rd.  On the 23rd I developed a fever of 101. Today I still do not have my voice and the fever has went away. The injection site has a red and swollen patch. I still feel tired and fatigued today.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Bone pain, Chills, Head discomfort, Hyperhidrosis, Myalgia
Clinical narrative: I developed fever of 101.7, had rigors, sweats, bone and muscle ache. I experienced a zapping sensation in my head that traveled down to my jaw. It felt like an electric shock that lasted a few seconds .It went from top of my head to my left jaw and ear. If felt the pain in my back molars.  This happened at least 15 times. In a 24 hour period. It was not a headache.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Toothache
Clinical narrative: I developed fever of 101.7, had rigors, sweats, bone and muscle ache. I experienced a zapping sensation in my head that traveled down to my jaw. It felt like an electric shock that lasted a few seconds .It went from top of my head to my left jaw and ear. If felt the pain in my back molars.  This happened at least 15 times. In a 24 hour period. It was not a headache.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Dyspnoea, Facial pain, Limb discomfort
Clinical narrative: -Severe chills -High Fever (Did not measure) -Trouble breathing -Neck pain/facial pain -Arm soreness -Weakness and SOB -Tachycardia - (Peak 132 BPM)
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Neck pain, Pyrexia, Tachycardia
Clinical narrative: -Severe chills -High Fever (Did not measure) -Trouble breathing -Neck pain/facial pain -Arm soreness -Weakness and SOB -Tachycardia - (Peak 132 BPM)
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Injection site pruritus, Injection site rash, Injection site swelling
Clinical narrative: Moderna COVID-19 Vaccine EUA  10 days after injection, itching, soreness, rash, swelling at injection site
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Feeling hot
Clinical narrative: Patient felt warm and lightheaded upon standing. Walked with assistance to lie down on a cot in the patient care tent. BP: 128/70, P: 90, Resp: 17. Patient drank some water and ate pretzels while sitting and denied dizziness after 20 minutes of sitting up. Patient left the building feeling well and denied any dizziness.
Age: 10.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site swelling, Periorbital swelling, Urticaria
Clinical narrative: Started swelling at injection site, bumps/hives all over the skin, and puffy eyes. No difficulty breathing and no shortness of breath. Will take OTC Benadryl and follow up with PCP as needed or ER if has difficulty breathing
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: Red firm lump at injection site with itching
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Positive COVID test after household exposure (daycare-child).  No symptoms.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Aphonia, Fatigue, Headache, Limb discomfort
Clinical narrative: I had the vaccine around 8 in the morning, a few hours later I lost my voice. I also developed a slight headache, arm soreness and fatigued. This lasted about 3 days.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Injection site swelling, Musculoskeletal stiffness, Nasopharyngitis
Clinical narrative: Injection site swelling, stiff neck/back/left arm, pain under armpit, feeling of coming down with a cold
Age: 27.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Hypoglycaemia
Clinical narrative: No issues with vaccine number 1. With receiving second dose he experienced light headedness and chronic low blood sugars for 4 days post vaccine. He was unable to rise his BS above 100 . He had to check his glucose every 2 hours. Since post 4 days he has been able to maintain his BS as normal.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Nausea
Clinical narrative: Severe chills from 11pm to 6am.; mild nauasea; headache in morning
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Dizziness, Sluggishness
Clinical narrative: Employee developed severe dizziness about 10 minutes after vaccine. Has a hx. of vertigo. Also had GI upset. Speech was sluggish, but she was oriented. Symptoms did not improve after an hour so significant other drove her home. Symptoms continued on 2/7/21 so Patient went to ER. Given IV fluids and sent home. Was able to return to work 3/9/21 and has been feeling fine.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Acidosis, Activated partial thromboplastin time prolonged, Alanine aminotransferase increased, Angiogram pulmonary abnormal
Clinical narrative: Abdominal pain, nausea and vomiting, shortness of breath, acidosis, hypoglycemia, death.  Onset of abdominal pain was 30 minutes after administration of the vaccine followed by 20+ episodes of vomiting and dry heaving.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Angiogram pulmonary normal, Anion gap, Ascites, Aspartate aminotransferase increased, Atelectasis
Clinical narrative: Abdominal pain, nausea and vomiting, shortness of breath, acidosis, hypoglycemia, death.  Onset of abdominal pain was 30 minutes after administration of the vaccine followed by 20+ episodes of vomiting and dry heaving.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Atypical mycobacterial infection, Bilirubin conjugated, Blood albumin, Blood alkaline phosphatase increased, Blood bicarbonate decreased
Clinical narrative: Abdominal pain, nausea and vomiting, shortness of breath, acidosis, hypoglycemia, death.  Onset of abdominal pain was 30 minutes after administration of the vaccine followed by 20+ episodes of vomiting and dry heaving.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Blood bilirubin, Blood creatinine increased, Blood glucose decreased, Blood lactic acid, Blood lactic acid normal
Clinical narrative: Abdominal pain, nausea and vomiting, shortness of breath, acidosis, hypoglycemia, death.  Onset of abdominal pain was 30 minutes after administration of the vaccine followed by 20+ episodes of vomiting and dry heaving.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pH decreased, Blood pH increased, Blood potassium decreased, Blood urea increased, Cholelithiasis
Clinical narrative: Abdominal pain, nausea and vomiting, shortness of breath, acidosis, hypoglycemia, death.  Onset of abdominal pain was 30 minutes after administration of the vaccine followed by 20+ episodes of vomiting and dry heaving.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram abdomen abnormal, Computerised tomogram pelvis abnormal, Death, Dyspnoea, Enteritis
Clinical narrative: Abdominal pain, nausea and vomiting, shortness of breath, acidosis, hypoglycemia, death.  Onset of abdominal pain was 30 minutes after administration of the vaccine followed by 20+ episodes of vomiting and dry heaving.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Fibrin D dimer, Hypoglycaemia, Ileus, International normalised ratio increased, N-terminal prohormone brain natriuretic peptide increased
Clinical narrative: Abdominal pain, nausea and vomiting, shortness of breath, acidosis, hypoglycemia, death.  Onset of abdominal pain was 30 minutes after administration of the vaccine followed by 20+ episodes of vomiting and dry heaving.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, PCO2 increased, Pericardial effusion, Platelet count decreased, Pleural effusion
Clinical narrative: Abdominal pain, nausea and vomiting, shortness of breath, acidosis, hypoglycemia, death.  Onset of abdominal pain was 30 minutes after administration of the vaccine followed by 20+ episodes of vomiting and dry heaving.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Proctitis, Retching, Troponin, Varices oesophageal, Vomiting
Clinical narrative: Abdominal pain, nausea and vomiting, shortness of breath, acidosis, hypoglycemia, death.  Onset of abdominal pain was 30 minutes after administration of the vaccine followed by 20+ episodes of vomiting and dry heaving.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: White blood cell count decreased
Clinical narrative: Abdominal pain, nausea and vomiting, shortness of breath, acidosis, hypoglycemia, death.  Onset of abdominal pain was 30 minutes after administration of the vaccine followed by 20+ episodes of vomiting and dry heaving.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pruritus, Injection site reaction, Rash macular
Clinical narrative: Injection site has red blotch that itches twelve days after receiving vaccine
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest pain, Painful respiration, Pericarditis
Clinical narrative: Moderate pain in chest behind sternum when breathing.     Admitted to Hospital on 1 February 2021.    Diagnosed as pericarditis.    Treatment:    Ibuprofen   600 mg  3x/day for 2 weeks, and Colchicine 0.6 mg  2x/day for 3 months.
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pericarditis, SARS-CoV-2 test
Clinical narrative: Moderate pain in chest behind sternum when breathing.     Admitted to Hospital on 1 February 2021.    Diagnosed as pericarditis.    Treatment:    Ibuprofen   600 mg  3x/day for 2 weeks, and Colchicine 0.6 mg  2x/day for 3 months.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Injection site pruritus, Injection site swelling, Injection site warmth
Clinical narrative: Swollen at the site within 7 days and continues to the present. No rash but hot to the touch, itches, & hurts.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pruritus, Injection site reaction, Injection site swelling, Rash erythematous
Clinical narrative: "Covid Arm" started on day 8, following initial injection; symptoms include red rash about 5 inches in length, from top of shoulder to mid-bicep area, slight swelling, and itching.